Cell and Gene Therapy

The latest market intelligence, insights and interviews covering the cell and gene therapy industry's most pressing challenges, from translation to automation, manufacturing to market access, viral vectors to bioreactors.

 

Cell and Gene Therapy
08/10/2018

An interview with Anthony Davies, Founder and CEO, Dark Horse Consulting

Cell and Gene Therapy
31/08/2018

Your therapy is cryopreserved and ready to change a patient's life. Is the cryogenic ecosystem in place to ensure you do not trip at the last...